Benzgalantamine - AlphaCognition
Alternative Names: Alpha 1062; ALPHA-1062 Intranasal; ALPHA-1062IN; Galantamine benzoate - AlphaCognition; Galantamine pro-drug - AlphaCognition; GLN-1062; Memogain; Pro-galantamine - AlphaCognition; ZUNVEYLLatest Information Update: 13 Apr 2025
At a glance
- Originator Galantos Pharma
- Developer AlphaCognition
- Class Alkaloids; Antidementias; Benzazepines; Benzoates; Nootropics; Small molecules
- Mechanism of Action Acetylcholinesterase inhibitors; Nicotinic receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Alzheimer's disease
- Preclinical Traumatic brain injuries